论文部分内容阅读
目的:探讨选择米非司酮+米索前列醇对产妇于早期实施终止妊娠后获得的临床效果。方法:选择我院2014年08月~2016年08月收治的早期终止妊娠患者85例作为本次实验对比观察对象;观察组39例以及对照组46例患者的分组依据为早期终止妊娠方法的不同;观察组:米非司酮+米索前列醇;对照组:米非司酮;通过对比终止早期妊娠效果以及用药不良反应等,以突出米非司酮+米索前列醇的临床联用价值。结果 :在终止早期妊娠效果方面,观察组同对照组终止早期妊娠患者之间的差异显著(P<0.05);在用药不良反应方面,观察组同对照组终止早期妊娠患者之间的差异显著(P<0.05)。结论 :对于早期终止妊娠患者,治疗药物选择米非司酮+米索前列醇,在降低用药不良反应以及提高终止早期妊娠效果方面,最终结果值得肯定。
Objective: To investigate the clinical effect of selecting mifepristone plus misoprostol for maternal termination of early pregnancy. Methods: 85 cases of early termination of pregnancy admitted to our hospital from August 2014 to August 2016 were selected as the control subjects. 39 cases in the observation group and 46 cases in the control group were grouped according to the method of early termination of pregnancy ; Observation group: mifepristone + misoprostol; control group: mifepristone; termination of early pregnancy by contrast and adverse drug reactions, in order to highlight the clinical combination of mifepristone + misoprostol value . Results: There was a significant difference between the observation group and the control group in terminating early pregnancy (P <0.05) in terminating the effect of early pregnancy. There was significant difference between the observation group and the control group in terminating early pregnancy in adverse drug reactions P <0.05). Conclusion: For patients with early termination of pregnancy, the choice of treatment for mifepristone + misoprostol should be concluded with a view to reducing the adverse drug reaction and increasing the effect of termination of early pregnancy.